S.Biomedics Balance Sheet Health
Financial Health criteria checks 5/6
S.Biomedics has a total shareholder equity of ₩12.3B and total debt of ₩10.4B, which brings its debt-to-equity ratio to 84.4%. Its total assets and total liabilities are ₩31.9B and ₩19.7B respectively.
Key information
84.4%
Debt to equity ratio
₩10.37b
Debt
Interest coverage ratio | n/a |
Cash | ₩10.66b |
Equity | ₩12.27b |
Total liabilities | ₩19.67b |
Total assets | ₩31.95b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A304360's short term assets (₩15.7B) exceed its short term liabilities (₩7.7B).
Long Term Liabilities: A304360's short term assets (₩15.7B) exceed its long term liabilities (₩11.9B).
Debt to Equity History and Analysis
Debt Level: A304360 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A304360's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A304360 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A304360 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 46.9% each year.